Advisory Services Network’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,350
Closed -$24K 1610
2020
Q4
$24K Buy
+1,350
New +$23.7K ﹤0.01% 2056
2015
Q2
Sell
-1
Closed -$1K 1417
2015
Q1
$1K Buy
+1
New +$427 ﹤0.01% 1228

Other funds holding CRDF

Advisory Services Network's CRDF Position: Q1 2021 in Review

Advisory Services Network sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 1,350 shares — an estimated $24K sold.

Advisory Services Network first reported a position in CRDF in Q1 2015 and held it in 2 quarters. The position peaked at $24K in Q4 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • Advisory Services Network reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 1,350 Cardiff Oncology shares in Q1 2021, an estimated $24K.
  • Advisory Services Network first reported a position in Cardiff Oncology in Q1 2015 and held it in 2 quarters.
  • Advisory Services Network's Cardiff Oncology position peaked at $24K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.